Myriad Genetics | MYGN - Current Liabilities

Stock Price
4.29
Daily Change
-0.09 -2.05%
Monthly
-26.54%
Yearly
-69.75%
Q1 Forecast
4.16

Myriad Genetics reported $148M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Agilent USD 2.35B 455M Sep/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
Bruker USD 1.28B 11.1M Dec/2025
Danaher USD 6.81B 483M Dec/2025
Exact Sciences USD 641.15M 56.89M Dec/2025
Hologic USD 951.3M 25.9M Dec/2025
Illumina USD 1.59B 377M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Mettler Toledo International USD 1.2B 5.99M Dec/2025
Myriad Genetics USD 148M 51.9M Sep/2025
OraSure Technologies USD 40.25M 2.1M Sep/2025
Pacific Biosciences Of California USD 63.21M 3.45M Sep/2025
Quest Diagnostics USD 2.28B 144M Dec/2025
Quidel USD 966.1M 198.2M Dec/2025
Repligen USD 131.14M 8.12M Sep/2025
Revvity USD 1.33B 108.5M Dec/2025
Standard Biotools USD 107.96M 9.94M Sep/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Veracyte USD 72.15M 4.28M Sep/2025
Waters USD 1.25B 235.17M Sep/2025